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Background and purpose   There is an ongoing need to review 
large series of total ankle replacements (TARs) for monitoring 
of changes in practice and their outcome. 4 national registries, 
including the Swedish Ankle Register, have previously reported 
their 5-year results. We now present an extended series with a 
longer follow-up, and with a 10-year survival analysis.
Patients and methods   Records of uncemented 3-component 
TARs were retrospectively reviewed, determining risk factors 
such as age, sex, and diagnosis. Prosthetic survival rates were cal-
culated with exchange or removal of components as endpoint—
excluding incidental exchange of the polyethylene meniscus. 
Results   Of the 780 prostheses implanted since 1993, 168 (22%) 
had been revised by June 15, 2010. The overall survival rate 
fell from 0.81 (95% CI: 0.79–0.83) at 5 years to 0.69 (95% CI: 
0.67–0.71) at 10 years. The survival rate was higher, although not 
statistically significantly so, during the latter part of the period 
investigated. Excluding the STAR prosthesis, the survival rate for 
all the remaining designs was 0.78 at 10 years. Women below the 
age of 60 with osteoarthritis were at a higher risk of revision, but 
age did not influence the outcome in men or women with rheu-
matoid arthritis. Revisions due to technical mistakes at the index 
surgery and instability were undertaken earlier than revisions for 
other reasons. 
Interpretation   The results have slowly improved during the 
18-year period investigated. However, we do not believe that 
the survival rates of ankle replacements in the near future will 
approach those of hip and knee replacements—even though 
improved instrumentation and design of the prostheses, together 
with better patient selection, will presumably give better results. 

 
The current generation of total ankle replacements, unce-
mented and avoiding rotational strain in a 3-component 
design with a polyethylene meniscus, have shown promis-
ing but varying results in medium-term and long-term reports 
(Kofoed 2004, Carlsson 2006, Doets and al. 2006, Wood et 
al. 2008, 2010, Bonnin et al. 2010, Karantana et al. 2010). 
National registries have a large number of patients operated on 
by different surgeons, and may thus give better insight into the 
current situation than what can be reported from a single sur-
geon or institution. 5-year prosthetic survival rates of between 
0.78 and 0.88 have been reported by the Norwegian, Swed-
ish, New Zealand, and Finnish national registries. (Fevang et 
al. 2007, Henricson et al. 2007, Hosman et al. 2007, Skyttä 
et al. 2010). Here we present longer-term follow-up of total 
arthroplasties reported to the Swedish Ankle Register.
Patients and methods 
The first of the third-generation total ankle replacements in 
Sweden were performed in 1993. Since then, all total ankle 
replacements are reported to a national register by each sur-
geon using a paper form. Hospital data, demographic data, 
date of index operation, date of revision surgery, operated side, 
diagnosis (primary or reason for revision), type of prosthesis, 
and—in cases of revision—the type of procedure are reported. 
Between April 14, 1993, and June 15, 2010, 780 primary 
total ankle replacements were reported to the register (Table 
1). Because of small numbers of the BP, AES, Mobility, and 
CCI prostheses—and due the similarity in design—these 
implants were analyzed together as a group called BP-type. 
The diagnoses were rheumatoid arthritis (RA) in 282 cases 
(36%), primary or idiopathic osteoarthritis (OA) in 185 (24%), 
posttraumatic arthritis (PtA) in 266 (34%), and various diag-
noses including hemophilia, hemochromatosis, and psoriatic 
arthritis in 47 cases (6%) (Table 2). 31 patients with RA and 
23 patients with other diagnoses had both ankles replaced. 
Statistics 
Survival curves were constructed according to Kaplan-Meier. 
Cox proportional regression was used to calculate hazard ratios 
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for Cox regression analysis were evaluated graphically in sur-
vival curves and log-minus-log plots and were estimated to be 
fullfilled. As endpoint, we used revision leading to exchange 
or extraction of 1 or more of the 3 prosthetic components 
with the exception of incidental exchange of the polyethylene 
insert (Henricson et al. 2011). 3 patients were revised bilat-
erally, and both ankles were included in the analyses. Inclu-
sion of bilateral observations in arthroplasty studies appears 
to have a negligible effect on survival estimates (Ranstam and 
Robertsson 2010).
Results 
17 hospitals had reported to the Swedish Ankle Register, but at 
the time of writing total ankle replacement is only performed 
at 6 hospitals in Sweden. 
168 ankles (22%) were revised (Table 3). 67 (40%) of them 
were revised because of loosening of the tibial and/or the talar 
component, and another 21 because of instability with or with-
out dislocation of the polyethylene (PE) meniscus. 19 ankles 
were considered to be technical failures by the surgeons per-
forming the revisions, with malpositioning of the tibial com-
ponent—too lateral or too medial, or at an incorrect angle. Use 
of a tibial component that was too short from front to back 
was also considered to be a technical error. Severe pain for no 
obvious reason in 11 ankles eventually resulted in revision. 
In addition, 17 ankles were revised because of severe wear or 
fracture of the mobile bearing component. 
30 cases (4%) were complicated by septic arthritis. 19 of 
those required revision and were included when we calculated 
prosthetic survival. The remaining cases were treated with 
antibiotics, synovectomy, and washout. 
The revison rate was 21–22% both in the unilateral and the 
bilateral ankles. There were 118 other secondary procedures 
that were not classified as revisions e.g. subtalar, triple, or 
talo-navicular fusions, debridement of the medial gutter, del-
toid ligament release, and Achilles tendon lengthening.
 The estimated overall 5-year survival rate was 0.81 (CI: 
0.79–0.83) and the 10-year survival rate was 0.69 (CI: 0.67–
0.71) (Figure 1 and Table 4). For RA patients, the estimated 
survival rate at 10 years was 0.72, for OA patients it was 
0.68, and for patients with posttraumatic arthritis it was 0.66 
(Figure 2). Compared to OA patients, HR for RA patients was 
0.9 (CI: 0.6–1.3) and compared to patients with posttraumatic 
Table 1. Numbers of ankle prostheses implanted in Sweden annually
Year  STAR  BP  AES  Hintegra Mobility  CCI  Total
1993  6         6
1994 13          13
1995 11          11
1996  8         8
1997 24          24
1998 34          34
1999 25          25
2000 45  1        46
2001 48          48
2002  40 21  3  10      74
2003  25 23  17  14      79
2004  17 29  16  4      66
2005  18 13  23  2  9    65
2006  7  11  21 6 21   66
2007  1  7  18   20   46
2008    4  17   32  16 69
2009        31  40 71
2010 a          19  10 29 
Total  322  109  115 36 136 66 780
a up to June 15
Table 2. Demographic data
  n  % females  Mean age (range)
          
RA  282  78  56 (18–86)
OA  185  48  62 (30–84)
PtA a   266  54  58 (25–86)
Other   47  47  56 (28–74)
All diagnoses  780  61  58 (18–86)
a posttrauma arthritis.      
Table 3. Reasons for revision
  Single-coated Double-coated         
  STAR  STAR  BP  AES  Hintegra Mobility  CCI  Total
Numbers  117  205 109  115  36  132  66 780 
Aseptic loosening  33  16  4  5  3  2  4  67
Technical error  8  8    1  2      19
Instability  1  2  5  8 1  3 1  21
Infection  3  10  1  2 1 2    19
Intractable pain  4  6        1    11
PE breakdown/fracture  7  4  3  1    2    17
Painful  varus    2 1  4  1   1 9
Fracture    1 3  1      5
Total  56  49  17 22  8 10  6 168Acta Orthopaedica 2011; 82 (6): 655–659  657
arthritis it was 0.7 (CI: 0.5–1.0). No statistically significant 
difference was found between the BP-type prostheses (BP, 
AES, Mobility, and CCI (p = 0.24). The 10-year survival rate 
of the single-coated STAR was 0.58 (Figure 3). The pros-
thetic survival rate was statistically significantly lower for the 
single-coated STAR prostheses implanted between 1993 and 
1999 than for the BP-type prostheses (HR = 1.7; CI: 1.1–9.5). 
The survival rates of the Hintegra and double-coated STAR 
prostheses were similar to that of the BP-type prostheses 
(Table 5).
Patients younger than 60 years of age with OA or post-
traumatic arthritis had a statistically significantly higher risk 
of revision than patients who were older than 60 years (HR 
= 1.8; CI: 1.3–2.8). This risk was statistically significant for 
women (HR = 2.0; CI: 1.2–3.6) but not for men. Age had no 
influence on the revision rate in patients with RA (HR = 1.4; 
CI: 0.8–2.4). Revisions due to technical error, infection, and 
instability were undertaken earlier than those undertaken as a 
result of component loosening and meniscal wear (Table 6). 
Discussion
The annual number of ankle replacements performed in 
Sweden (with 9 million inhabitants) increased until 2002, and 
then a steady state of around 70 per year was reached (Table 
1). This indicates 1 replacement per 100,000 inhabitants over 
the age of 15. The corresponding figure is the same in Norway 
(http://nrlweb.ihelse.net) and Scotland (www.arthro.scot.nhs.
uk) but twice as many replacements are performed annually 
in Finland (Skyttä et al. 2010) and 3 times as many are per-
formed in New Zealand (www.cdhb.govt.nz). In Denmark, the 
corresponding figure is 2.8 (www.sst.dk) and in England and 
Wales it is 1.2 (www.njrcentre.org.uk).
Earlier reports from 4 national registries have shown a 
5-year survival rate of 78–88% (Henricson et al. 2007, Fevang 
et al. 2007, Hosman et al. 2007, Skyttä et al. 2010). However, 
the definitions of a revision of a total ankle replacement were 
not identical in these reports. Here, for the first time, we pres-
Figure 1. Estimated cumulative survival and 
95% CI for all 780 arthroplasties.
Table 4. Life table 
  
 Interval  No.  No. of  Cumulative  95% CI
(years) entering  events  proportion 
  the interval    surviving at the 
         end of the interval
  
0–1  780  46  0.94 0.93–0.95
1–2  674  33  0.89 0.88–0.90
2–3  568  17  0.86 0.85–0.87
3–4  496  15  0.83 0.82–0.84
4–5  434  14  0.81 0.79–0.83
5–6  355  13  0.77 0.75–0.79
6–7  288  8  0.75 0.73–0.77
7–8  219  5  0.73 0.71–0.75
8–9  165  5  0.70 0.68–0.72
9–10 114  2  0.69 0.67–0.71
Figure 2. Estimated cumulative survival for 
ankles replaced due to rheumatoid arthritis 
(purple), osteoarthritis (red), and posttraumatic 
osteoarthritis (green).
Figure 3. Estimated survival for the different 
designs implanted. The blue curve repre-
sents the BP-type designs, the green curve 
the Hintegra, the purple curve the double-
coated STAR, and the red curve the single-
coated STAR prostheses.
Table 5. Hazard ratio (HR) of survival rates for different prostheses
Prosthesis  HR  95% CI
BP-type  1 Reference
Hintegra  1.2 0.57–2.5
STAR I (single-coated)  1.7  1.1–2.5
STAR II (double-coated)  1.1   0.75–1.6658  Acta Orthopaedica 2011; 82 (6): 655–659
ent data from a national register for up to 18 years of follow-
up of third-generation total ankle replacements. In our first 
report (Henricson et al. 2007) we found a survival rate of 78% 
(95% CI: 74–82) at 5 years for the total material. The endpoint 
for the calculations was exchange or removal of any of the 
components (Henricson et al. 2011).
In the present study, the overall 10-year survival (with iden-
tical endpoint) was estimated to be 69% (CI: 67–71). When 
we excluded the single- and double-coated STAR prostheses 
(for reasons given below), the 10-year survival was estimated 
to be 0.78 (CI: 0.72–0.83).
As a rule, specialized units report higher survival rates. 
Thus, Wood et al. (2008) found a 10-year survival rate of 0.80 
(CI: 0.71–0.90) for 200 STAR prostheses. In smaller material, 
Doets et al. (2006) found a 10-year survival rate of 0.89 (CI: 
0.82–97) for 74 BP prostheses and Karantana et al. (2010) 
found an 8-year survival rate of 0.84 (CI: 0.67–0.92) for 52 
STAR prostheses. Bonnin et al. (2010) reported a 10-year sur-
vival rate of 0.85 (CI: 0.75–0.95) for 98 Salto prostheses.
In Sweden, units that were not satisfied with the results after 
having performed a limited number of replacements decided to 
perform arthrodeses only and referred candidates for replace-
ment to specialized units. This may have contributed to better 
results in later years.
We found a statistically significant difference in perfor-
mance of the single-coated STAR prosthesis compared with 
the other designs. It performed worse. The only published 
randomized study comparing different designs of total ankle 
replacements found better performance of the STAR prosthe-
sis than of the BP prosthesis, but the difference was not sta-
tistically significant. That study included both single-coated 
and double-coated STAR prostheses (Wood et al. 2009). Also, 
2 systematic reviews of the outcome of total ankle replace-
ments have been published. Stengel et al. (2005) found the 
weighted 5-year survival of 1,107 third-generation total ankle 
replacements to be 0.91 (CI: 0.84–0.97). No significant dif-
ferences between the prostheses included (STAR, ESKA, 
Ramses, LCS, and BP) were found. Gougoulias et al. (2010) 
reported an overall revision rate of 10% for 801 third-genera-
tion total ankle replacements (STAR, BP, HINTEGRA, Salto, 
and Mobility) and no superiority of any of the prostheses after 
a follow-up of 5 years. 
Aseptic loosening of components was the most common 
reason for revision, and it was mainly a problem with the 
STAR prosthesis (Table 3). The STAR prosthesis was the first 
third-generation design to be introduced in Sweden, and most 
surgeons were therefore in a learning phase. Also, the STAR 
prosthesis is technically demanding and the instrumentation 
was inferior, at least during the first years. The STAR prosthe-
sis is no longer used in Sweden (Table 1). The single-coated 
STAR is not manufactured any more. 
As expected, technical mistakes at surgery, infections, and 
instability problems resulted in early revision. Meniscal wear 
and aseptic loosening, notably of the talar component, resulted 
in later revision. The reason may be that loosening of the tibial 
component can be seen more easily in radiographs than loos-
ening of the talar component. 
In the present study, the risk of revision was increased for 
patients younger than 60 years with primary osteoarthritis or 
posttraumatic osteoarthritis. This difference was only statisti-
cally significant for women. The revision rate in patients with 
rheumatoid arthritis was not influenced by age. The revision 
rate in younger patients was also elevated in our earlier report 
from the Swedish Ankle Register (Henricson et al. 2007), but 
not in the reports from the Norwegian, New Zealand, or Finn-
ish registers (Fevang et al. 2007, Hosman et al. 2007, Skyttä et 
al. 2010). Younger patients have higher demands and a higher 
activity level than older patients, which might affect the lon-
gevity of a total ankle replacement. 
The infection rate of 4% that we found involved all deep 
infections, including late hematogenous infections; the 2% 
that led to revision was at the same level as in other reports. 
Thus, Doets et al. (2006) found a rate of 3%, Raikin et al. 
(2010) found a rate of 3%, and Whalen et al. (2010) reported 
7%. The anterior incision used for total ankle replacement 
surgery is considered to indicate a high risk of healing com-
plications. Other risk factors are smoking, peripheral vascular 
disease, and cardiovascular disease (Whalen et al. 2010) but 
Raikin et al. (2010) only found inflammatory arthritis to be a 
statistically significant risk factor for major wound complica-
tions.
The surgical challenge in performing a total ankle replace-
ment and the long learning curve is well known (Andersson et 
al. 2003, Carlsson 2006, Henricson and Ågren 2007), and in 
our earlier study we found that experience reduced the revi-
sion rate (Henricson et al. 2007). This study supports that find-
ing, since the results have improved with time. 
Bai et al. (2010) found that complications and secondary 
surgical procedures were higher in posttraumatic patients than 
in patients with primary osteoarthritis, but we found similar 
survival rates concerning different diagnoses (Figure 2).
An obvious limitation of reports from national registries is 
the uncertainty of adequate reporting from different centers. 
Table 6. Time (years) and 95% CI from index surgery to revision
      
Reason for revision  Mean  95% CI
Valgus malalignment  1.0    0.2–1.8
Infection  1.2    0.6–1.8
Technical error  1.3    0.6–2.0
Fracture  1.4    0.3–3.0
Instability  1.8    0.9–2.7
Loosening tibia  2.5    1.7–3.3
Intractable pain  2.5    1.6–3.4
Varus malalignment  2.9    1.3–4.4
Loosening talus and tibia  5.3    4.0–6.5
PE breakdown/fracture  5.6    3.8–7.5
Loosening talus  7.8    6.3–9.2Acta Orthopaedica 2011; 82 (6): 655–659  659
We are personally acquainted with every surgeon who per-
forms total ankle replacement in Sweden. Furthermore, we 
have compared data with information from hospital records, 
and in recent years also with data from the Nation Health 
Authority. The reporting rate can therefore be considered to 
be complete. 
Another limitation of our study is the problem of bilateral 
cases, which were included in our survival analyses. 3 patients 
were revised bilaterally. However, Ranstam and Robertsson 
(2010) reviewed the literature on the effect of including bilat-
eral observations and found that all reports suggest a negli-
gible effect on survival estimates.
It seems appropriate to inform presumptive patients that the 
probability of retaining an ankle arthroplasty of modern design 
for 10 years is about 80%. They should also be informed that 
when a total ankle replacement fails, there is the possibility 
of performing a successful ankle arthrodesis by various meth-
ods: intramedullary nailing through a femoral head autograft 
(Thomason and Eyres 2008), anterior plating (Plaass et al. 
2009, Berkowitz et al. 2011), or the use of an intramedullary 
nail through a trabecular metal implant (Henricson and Ryd-
holm 2010). Caution can no doubt be recommended with post-
traumatic cases and with younger patients, especially younger 
women with osteoarthritis. 
AH and ÅC: introduction and maintenance of the register, analysis, and writ-
ing of the manuscript. JÅN: statistical analysis. 
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